– Bloomberg
Evogene Q2 Revenue Grows 131% YoY, Here Is What You Need To Know
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) Q2 2022 revenue was $312,000, an increase of 131% compared to $135,000 in the same period the previous year.
BlackRock Cuts Japanese Stocks To “Underweight” On Hawkish BOJ Risks
– Bloomberg
Related Posts
If You Invested $100 In This Stock 10 Years Ago, You Would Have $1,000 Today
UnitedHealth Group (NYSE:UNH) has outperformed the market over the past 10 years by 14.45% on an annualized basis producing an average annual return of 26.12%. Currently, UnitedHealth Group has a market capitalization of $508.66 billion.
Coffeezilla Takes A Dig At Crypto As Interest Hits Near 5-Year Low: ‘Because Average Person Does Know..’
Global Google search traffic for the term “cryptocurrency” has reached its lowest point in five years.
What Happened: Data from Google Trends shows the current trend score stands at a mere 9, while it previously peaked on May 9, 2021, at a score of 100.
150-Year Old Opioid Drugmaker Mallinckrodt Files For Bankruptcy For Second Time
Mallinckrodt Plc (NYSE: MNK), a venerable pharmaceutical company with a history spanning almost 150 years, is poised to file for bankruptcy for the